Abh Biochem Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-12-2024
- Paid Up Capital ₹ 1.00 M
as on 09-12-2024
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.79 M
as on 09-12-2024
- Revenue -54.04%
(FY 2021)
- Profit -19.80%
(FY 2021)
- Ebitda 10.81%
(FY 2021)
- Net Worth 15.41%
(FY 2021)
- Total Assets 13.57%
(FY 2021)
About Abh Biochem
The Corporate was formerly known as B.S. Biochem Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.79 M.
Hawa Singh and Bimal Singh serve as directors at the Company.
- CIN/LLPIN
U24100HR2010PTC040434
- Company No.
040434
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Apr 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Abh Biochem Private Limited offer?
Abh Biochem Private Limited offers a wide range of products and services, including Textile Enzymes, Denim Enzyme, Cleaning Liquids & Wipes, Kitchen Cleaners, Oils, Grease & Lubricants, Machine Oils, Soaps, Detergent Powder & Cakes, Fabric Pre-Post Wash, Textile Softeners, Silicone Textile Softeners.
Who are the key members and board of directors at Abh Biochem?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hawa Singh  | Director | 22-Apr-2010 | Current |
| Bimal Singh | Director | 22-Apr-2010 | Current |
Financial Performance of Abh Biochem.
Abh Biochem Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 54.04% decrease. The company also saw a substantial fall in profitability, with a 19.8% decrease in profit. The company's net worth Soared by an impressive increase of 15.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Abh Biochem?
In 2021, Abh Biochem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 Jun 2020 | ₹0.79 M | Open |
Others Creation Date: 29 Apr 2013 | ₹4.00 M | Open |
How Many Employees Work at Abh Biochem?
Unlock and access historical data on people associated with Abh Biochem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abh Biochem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abh Biochem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
